Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

The company targets markets in immunology, oncology ... While we acknowledge the potential of biotech companies, our conviction lies in the belief that AI stocks hold greater promise for ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options in inflammatory bowel disease, atopic dermatitis, myasthenia gravis and ...

Several biotechnology companies are embracing these cutting ... Sign Up For Free » Here are three fantastic biotech stocks harnessing the power of AI that could make a great addition to your ...

China is teeming with promising science in areas such as oncology and immunology ... comes not only from other VC firms or even biotech companies. It’s coming from big pharma, he said.

Respiratory illnesses that progress to pediatric asthma exacerbations are linked to a steeper rise in interferon expression in airways and blood.

This is not about doing it all but about translating external trends into actionable strategies that keep companies ... the future of biotech The convergence of oncology and immunology is not ...

About Zenas BioPharma, Inc. Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based ...

Just a few months after raising $200 million in third-round financing, immunology specialist Zenas ... acceleration in the number of biotech companies seeking public listings after a two-year ...